Diagnosis and management of group B streptococcus in pregnancy

Obstetrics and Gynecology Clinics of North America

Volumn 41, Issue 4, 2014, Pages 629-647

  Ahmadzia, Homa K ^a   Heine, R Phillips ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diagnosis; Group B streptococcus; Intrapartum prophylaxis; Neonate; Pregnancy; Screening

Indexed keywords

AMPICILLIN; CEFAZOLIN; CLINDAMYCIN; ERYTHROMYCIN; GROUP B STREPTOCOCCUS VACCINE; PENICILLIN DERIVATIVE; PENICILLIN G; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

AMNIONITIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; BACTEREMIA; CULTURE MEDIUM; ENDOCARDITIS; ENDOMETRITIS; FALSE NEGATIVE RESULT; GROUP B STREPTOCOCCAL INFECTION; GROUP B STREPTOCOCCUS SEPSIS; HUMAN; INCIDENCE; MEDICAL ERROR; MENINGITIS; MORBIDITY; MORTALITY; NEWBORN SEPSIS; OPTICAL IMMUNOASSAY; PENICILLIN ALLERGY; PNEUMONIA; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRETERM PREMATURE RUPTURE OF MEMBRANE; PREVALENCE; PYELONEPHRITIS; RECTAL SWAB; REVIEW; SEPSIS; TREATMENT DURATION; URINARY TRACT INFECTION; VAGINAL SWAB; WOUND INFECTION; ADULT; DRUG ADMINISTRATION; FEMALE; INFANT, NEWBORN, DISEASES; MICROBIOLOGY; NEWBORN; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURITY; PRENATAL DIAGNOSIS; PREVENTION AND CONTROL; PROCEDURES; RISK FACTOR; STREPTOCOCCAL INFECTIONS; UNITED STATES; VERTICAL TRANSMISSION;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; PRENATAL DIAGNOSIS; RISK FACTORS; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; UNITED STATES;

EID: 84912062110     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2014.08.009     Document Type: Review

References (77)

1. Regan J.A., Klebanoff M.A., Nugent R.P. The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol 1991, 77(4):604-610.
2. Yancey M.K., Duff P., Kubilis P., et al. Risk factors for neonatal sepsis. Obstet Gynecol 1996, 87(2):188-194.
3. Stoll B.J., Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J 1998, 17(6):499-503.
4. Phares C.R., Lynfield R., Farley M.M., et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008, 299(17):2056-2065.
5. Braun T.I., Pinover W., Sih P. Group B streptococcal meningitis in a pregnant woman before the onset of labor. Clin Infect Dis 1995, 21(4):1042-1043.
6. Guerin J.M., Leibinger F., Mofredj A., et al. Streptococcus B meningitis in post-partum. JInfect 1997, 34(2):151-153.
7. Palys E.E., Li J., Gaut P.L., et al. Tricuspid valve endocarditis with Group B Streptococcus after an elective abortion: the need for new data. Infect Dis Obstet Gynecol 2006, 2006:43253.
8. Schrag S., Gorwitz R., Fultz-Butts K., et al. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002, 51(RR-11):1-22.
9. Hood M., Janney A., Dameron G. Beta hemolytic streptococcus group B associated with problems of the perinatal period. Am J Obstet Gynecol 1961, 82:809-818.
10. Baker C.J., Barrett F.F. Transmission of group B streptococci among parturient women and their neonates. JPediatr 1973, 83(6):919-925.
11. Schrag S.J., Zell E.R., Lynfield R., et al. Apopulation-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. NEngl J Med 2002, 347(4):233-239.
12. Franciosi R.A., Knostman J.D., Zimmerman R.A. Group B streptococcal neonatal and infant infections. JPediatr 1973, 82(4):707-718.
13. Baker C.J., Clark D.J., Barrett F.F. Selective broth medium for isolation of group B streptococci. Appl Microbiol 1973, 26(6):884-885.
14. Schrag S.J., Zywicki S., Farley M.M., et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. NEngl J Med 2000, 342(1):15-20.
15. Valkenburg-van den Berg A.W., Sprij A.J., Dekker F.W., et al. Association between colonization with Group B Streptococcus and preterm delivery: a systematic review. Acta Obstet Gynecol Scand 2009, 88(9):958-967.
16. Regan J.A., Klebanoff M.A., Nugent R.P., et al. Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol 1996, 174(4):1354-1360.
17. Krohn M.A., Hillier S.L., Baker C.J. Maternal peripartum complications associated with vaginal group B streptococci colonization. JInfect Dis 1999, 179(6):1410-1415.
18. Gilstrap L.C., Cunningham F.G. The bacterial pathogenesis of infection following cesarean section. Obstet Gynecol 1979, 53(5):545-549.
19. Martens M.G., Kolrud B.L., Faro S., et al. Development of wound infection or separation after cesarean delivery. Prospective evaluation of 2,431 cases. JReprod Med 1995, 40(3):171-175.
20. Hill J.B., Sheffield J.S., McIntire D.D., et al. Acute pyelonephritis in pregnancy. Obstet Gynecol 2005, 105(1):18-23.
21. Blanco J.D., Gibbs R.S., Castaneda Y.S. Bacteremia in obstetrics: clinical course. Obstet Gynecol 1981, 58(5):621-625.
22. Cape A., Tuomala R.E., Taylor C., et al. Peripartum bacteremia in the era of group B streptococcus prophylaxis. Obstet Gynecol 2013, 121(4):812-818.
23. Thomsen A.C., Morup L., Hansen K.B. Antibiotic elimination of group-B streptococci in urine in prevention of preterm labour. Lancet 1987, 1(8533):591-593.
24. Romero R., Oyarzun E., Mazor M., et al. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol 1989, 73(4):576-582.
25. Mittendorf R., Williams M.A., Kass E.H. Prevention of preterm delivery and low birth weight associated with asymptomatic bacteriuria. Clin Infect Dis 1992, 14(4):927-932.
26. Verani J.R., McGee L., Schrag S.J. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep 2010, 59(RR-10):1-36.
27. Aungst M., King J., Steele A., et al. Low colony counts of asymptomatic group B streptococcus bacteriuria: a survey of practice patterns. Am J Perinatol 2004, 21(7):403-407.
28. Anderson B.L., Simhan H.N., Simons K.M., et al. Untreated asymptomatic group B streptococcal bacteriuria early in pregnancy and chorioamnionitis at delivery. Am J Obstet Gynecol 2007, 196(6):524.e1-524.e5.
29. Newman T.B., Puopolo K.M., Wi S., et al. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010, 126(5):903-909.
30. Group B streptococcal infections in pregnancy. ACOG Technical Bulletin Number 170-July 1992. Int J Gynaecol Obstet 1993, 42(1):55-59.
31. Rouse D.J., Goldenberg R.L., Cliver S.P., et al. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 1994, 83(4):483-494.
32. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Recomm Rep 1996, 45(RR-7):1-24.
33. Yancey M.K., Schuchat A., Brown L.K., et al. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996, 88(5):811-815.
34. Badri M.S., Zawaneh S., Cruz A.C., et al. Rectal colonization with group B streptococcus: relation to vaginal colonization of pregnant women. JInfect Dis 1977, 135(2):308-312.
35. Philipson E.H., Palermino D.A., Robinson A. Enhanced antenatal detection of group B streptococcus colonization. Obstet Gynecol 1995, 85(3):437-439.
36. American College of Obstetricians and Gynecologists Committee on Obstetric Practice ACOG Committee Opinion No. 485: prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol 2011, 117(4):1019-1027.
37. Orafu C., Gill P., Nelson K., et al. Perianal versus anorectal specimens: is there a difference in Group B streptococcal detection?. Obstet Gynecol 2002, 99(6):1036-1039.
38. Jamie W.E., Edwards R.K., Duff P. Vaginal-perianal compared with vaginal-rectal cultures for identification of group B streptococci. Obstet Gynecol 2004, 104(5 Pt 1):1058-1061.
39. Price D., Shaw E., Howard M., et al. Self-sampling for group B streptococcus in women 35 to 37 weeks pregnant is accurate and acceptable: a randomized cross-over trial. JObstet Gynaecol Can 2006, 28(12):1083-1088.
40. Mercer B.M., Taylor M.C., Fricke J.L., et al. The accuracy and patient preference for self-collected group B Streptococcus cultures. Am J Obstet Gynecol 1995, 173(4):1325-1328.
41. Morales W.J., Lim D. Reduction of group B streptococcal maternal and neonatal infections in preterm pregnancies with premature rupture of membranes through a rapid identification test. Am J Obstet Gynecol 1987, 157(1):13-16.
42. Honest H., Sharma S., Khan K.S. Rapid tests for group B Streptococcus colonization in laboring women: a systematic review. Pediatrics 2006, 117(4):1055-1066.
43. Goodrich J.S., Miller M.B. Comparison of culture and 2 real-time polymerase chain reaction assays to detect group B Streptococcus during antepartum screening. Diagn Microbiol Infect Dis 2007, 59(1):17-22.
44. Block T., Munson E., Culver A., et al. Comparison of carrot broth- and selective Todd-Hewitt broth-enhanced PCR protocols for real-time detection of Streptococcus agalactiae in prenatal vaginal/anorectal specimens. JClin Microbiol 2008, 46(11):3615-3620.
45. Money D., Dobson S., Cole L., et al. An evaluation of a rapid real time polymerase chain reaction assay for detection of group B streptococcus as part of a neonatal group B streptococcus prevention strategy. JObstet Gynaecol Can 2008, 30(9):770-775.
46. Boyer K.M., Gotoff S.P. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. NEngl J Med 1986, 314(26):1665-1669.
47. Matorras R., Garcia-Perea A., Madero R., et al. Maternal colonization by group B streptococci and puerperal infection; analysis of intrapartum chemoprophylaxis. Eur J Obstet Gynecol Reprod Biol 1991, 38(3):203-207.
48. Tuppurainen N., Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol 1989, 73(4):583-587.
49. Ohlsson A., Shah V.S. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev 2013, (1). CD007467.
50. Van Dyke M.K., Phares C.R., Lynfield R., et al. Evaluation of universal antenatal screening for group B streptococcus. NEngl J Med 2009, 360(25):2626-2636.
51. Salkind A.R., Cuddy P.G., Foxworth J.W. The rational clinical examination. Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy. JAMA 2001, 285(19):2498-2505.
52. Rimawi R.H., Cook P.P., Gooch M., et al. The impact of penicillin skin testing on clinical practice and antimicrobial stewardship. JHosp Med 2013, 8(6):341-345.
53. Baker C.J., Byington C.L., Polin R.A. Policy statement-Recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatrics 2011, 128(3):611-616.
54. Baker C.J., Kasper D.L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. NEngl J Med 1976, 294(14):753-756.
55. Baker C.J., Rench M.A., Edwards M.S., et al. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. NEngl J Med 1988, 319(18):1180-1185.
56. Kim S.Y., Russell L.B., Park J., et al. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. Vaccine 2014, 32(17):1954-1963.
57. Davies H.D., Miller M.A., Faro S., et al. Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin Infect Dis 2004, 39(8):1129-1135.
58. Gavino M., Wang E. Acomparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization. Am J Obstet Gynecol 2007, 197(4):388.e1-388.e4.
59. Young B.C., Dodge L.E., Gupta M., et al. Evaluation of a rapid, real-time intrapartum group B streptococcus assay. Am J Obstet Gynecol 2011, 205(4):372.e1-372.e6.
60. Stoll B.J., Hansen N.I., Sanchez P.J., et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011, 127(5):817-826.
61. Verani J.R., Spina N.L., Lynfield R., et al. Early-onset group B streptococcal disease in the United States: potential for further reduction. Obstet Gynecol 2014, 123(4):828-837.
62. Barcaite E., Bartusevicius A., Tameliene R., et al. Prevalence of maternal group B streptococcal colonisation in European countries. Acta Obstet Gynecol Scand 2008, 87(3):260-271.
63. Edwards R.K., Clark P., Sistrom C.L., et al. Intrapartum antibiotic prophylaxis 1: relative effects of recommended antibiotics on gram-negative pathogens. Obstet Gynecol 2002, 100(3):534-539.
64. Bizzarro M.J., Dembry L.M., Baltimore R.S., et al. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008, 121(4):689-696.
65. Puopolo K.M., Eichenwald E.C. No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics 2010, 125(5):e1031-e1038.
66. de Cueto M., Sanchez M.J., Sampedro A., et al. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 1998, 91(1):112-114.
67. Turrentine M.A., Greisinger A.J., Brown K.S., et al. Duration of intrapartum antibiotics for group B streptococcus on the diagnosis of clinical neonatal sepsis. Infect Dis Obstet Gynecol 2013, 2013:525878.
68. Fairlie T., Zell E.R., Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstet Gynecol 2013, 121(3):570-577.
69. Barber E.L., Zhao G., Buhimschi I.A., et al. Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery. Obstet Gynecol 2008, 112(2 Pt 1):265-270.
70. Fiore Mitchell T., Pearlman M.D., Chapman R.L., et al. Maternal and transplacental pharmacokinetics of cefazolin. Obstet Gynecol 2001, 98(6):1075-1079.
71. Laiprasert J., Klein K., Mueller B.A., et al. Transplacental passage of vancomycin in noninfected term pregnant women. Obstet Gynecol 2007, 109(5):1105-1110.
72. Bergeron M.G., Ke D., Menard C., et al. Rapid detection of group B streptococci in pregnant women at delivery. NEngl J Med 2000, 343(3):175-179.
73. Edwards R.K., Novak-Weekley S.M., Koty P.P., et al. Rapid group B streptococci screening using a real-time polymerase chain reaction assay. Obstet Gynecol 2008, 111(6):1335-1341.
74. El Helali N., Nguyen J.C., Ly A., et al. Diagnostic accuracy of a rapid real-time polymerase chain reaction assay for universal intrapartum group B streptococcus screening. Clin Infect Dis 2009, 49(3):417-423.
75. Boyer K.M., Gadzala C.A., Kelly P.D., et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. JInfect Dis 1983, 148(5):810-816.
76. Lijoi D., Di Capua E., Ferrero S., et al. The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study. Arch Gynecol Obstet 2007, 275(5):373-379.
77. Berardi A., Rossi C., Biasini A., et al. Efficacy of intrapartum chemoprophylaxis less than 4 hours duration. JMatern Fetal Neonatal Med 2011, 24(4):619-625.